Jun 1, 2020

The role of antithrombotic therapy in heart failure

Current Pharmaceutical Design
Christina ChrysohoouDimitrios Tousoulis


Heart failure is a major contributor to global morbidity and mortality burden affecting approximately 1-2% of adults in developed countries, mounting to over 10% in individuals aged >70 years old. Heart failure is characterized by a prothrombotic state and increased rates of stroke and thromboembolism have been reported in heart failure patients compared with the general population. However, the impact of antithrombotic therapy on heart failure remains controversial. Administration of antiplatelet or anticoagulant therapy is the obvious (and well-established) choice in heart failure patients with a cardiovascular comorbidity that necessitates their use, such as coronary artery disease or atrial fibrillation. In contrast, antithrombotic therapy has not demonstrated any clear benefit when administered for heart failure per se, i.e. with heart failure being the sole indication. Randomized studies have reported decreased stroke rates with warfarin use in patients with heart failure with reduced left ventricular ejection fraction, but at the expense of excessive bleeding. Non-vitamin K oral anticoagulants have shown a better safety profile in heart failure patients with atrial fibrillation compared with warfarin, however, current ev...Continue Reading

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Cerebrovascular Accident
Nonclinical Randomization
Antiplatelet Agents
Coronary Arteriosclerosis
RNA, Untranslated
Antiplatelet Therapy
Mental State (Observable Entity)
Left Ventricular Ejection Fraction

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Croatian Medical Journal
Davor MiličićMate Petričević
Expert Review of Cardiovascular Therapy
Freek W A Verheugt
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
F De Lorenzo, V V Kakkar
Journal of the American College of Cardiology
Gregory Y H Lip, C R Gibbs
The Cochrane Database of Systematic Reviews
Gregory Y H LipRon Pisters
© 2020 Meta ULC. All rights reserved